Who We Are


TRIZ Biopharma Innovation is the only company globally developing Dynamic Self-Adapting Chemical Structures—medications that evolve with your body. Our technology produces self-organizing structures that adapt to your receptors, much like immunoglobulins combat infections. By leveraging TRIZ (Theory of Inventive Problem Solving, based on Patterns of Evolution) and AI, we create millions of variants within a single dose, guaranteeing precision that static drugs cannot achieve. This represents personalized medicine at its finest.

Quasi-living Drugs




The figure presents a pie chart where the area reflects the degree of freedom (variability, adaptability) of various “systems” in relation to external conditions:




MoLRx




One promising direction in cancer treatment is the development of gene therapy based on antisense oligonucleotides.




Multi-Drug Synergism




Our research is one of the most prospective ways to create such medicines based on the synergy already registered and studied drugs in admixture.